TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
R$Â 90.54
0.00%
(0.00) Siku 1
6 Okt, 15:21:39 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya TAKP34...
Mtaji wa soko
58.89B
Wastani wa kiasi cha mauzo
36.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$Â 102.65
Chini kwa wiki 52
R$Â 70.80
Hisa za wawekezaji
1.60B
Idadi ya wafanyakazi
elfu 47
Mtaji wa soko
58.89B
Wastani wa kiasi cha mauzo
36.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$Â 102.65
Chini kwa wiki 52
R$Â 70.80
Hisa za wawekezaji
1.60B
Idadi ya wafanyakazi
elfu 47
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
saa 4 zilizopita
Takeda Pharmaceutical stock after-hours at EUR 16.55: quote at 8:08 p.m. CEST from Lang & Schwarz
Simply Wall Street
·
siku 1 iliyopita
Should Phase 3 Psoriasis Win Require Action From Takeda Stock Investors?
Wasifu
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Kuhusu Takeda Pharmaceutical Co Ltd BDR
Afisa Mkuu Mtendaji (CEO)Christophe Weber | Christophe Weber
Wafanyakazielfu 47
Lilianzishwa12 Jun 1781
Makao makuu-
Sekta-
Tovutitakeda.com